IL27 and neoplasm: When drug resistance occurs, the downstream effects of IL27 are blocked or weakened, while the expression of IL27 may continue to increase due to the negative feedback mechanism as the tumor develops, which could cause a phenomenon in which high expression of IL27 may not have any prognostic value or may be associated with worse survival in resistant patients due to the downstream effects of IL27 being blocked or weakened.